FOXR2 in cancer development: emerging player and therapeutic opportunities.

Fuente: PubMed
Guardado en:
Detalles Bibliográficos
Autores principales: Yang, Piao, Sheykhhasan, Mohsen, Heidari, Reza, Chamanara, Mohsen, Dama, Paola, Ahmadieh-Yazdi, Amirhossein, Manoochehri, Hamed, Tanzadehpanah, Hamid, Mahaki, Hanie, Kalhor, Naser, Dirbaziyan, Ashkan, Al-Musawi, Sharafaldin
Formato: Artículo científico
Lenguaje:en
Publicado: Oncology research 2025
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1868266249925951489
author Yang, Piao
Sheykhhasan, Mohsen
Heidari, Reza
Chamanara, Mohsen
Dama, Paola
Ahmadieh-Yazdi, Amirhossein
Manoochehri, Hamed
Tanzadehpanah, Hamid
Mahaki, Hanie
Kalhor, Naser
Dirbaziyan, Ashkan
Al-Musawi, Sharafaldin
author_facet Yang, Piao
Sheykhhasan, Mohsen
Heidari, Reza
Chamanara, Mohsen
Dama, Paola
Ahmadieh-Yazdi, Amirhossein
Manoochehri, Hamed
Tanzadehpanah, Hamid
Mahaki, Hanie
Kalhor, Naser
Dirbaziyan, Ashkan
Al-Musawi, Sharafaldin
Yang, Piao
Sheykhhasan, Mohsen
Heidari, Reza
Chamanara, Mohsen
Dama, Paola
Ahmadieh-Yazdi, Amirhossein
Manoochehri, Hamed
Tanzadehpanah, Hamid
Mahaki, Hanie
Kalhor, Naser
Dirbaziyan, Ashkan
Al-Musawi, Sharafaldin
collection PubMed - marine biology
contents FOXR2 in cancer development: emerging player and therapeutic opportunities. Yang, Piao Sheykhhasan, Mohsen Heidari, Reza Chamanara, Mohsen Dama, Paola Ahmadieh-Yazdi, Amirhossein Manoochehri, Hamed Tanzadehpanah, Hamid Mahaki, Hanie Kalhor, Naser Dirbaziyan, Ashkan Al-Musawi, Sharafaldin Humans Neoplasms Forkhead Transcription Factors Animals Prognosis Carcinogenesis Gene Expression Regulation, Neoplastic Cancer, a leading cause of global mortality, remains a significant challenge to increasing life expectancy worldwide. Forkhead Box R2 (FOXR2), identified as an oncogene within the FOX gene family, plays a crucial role in developing various endoderm-derived organs. Recent studies have elucidated FOXR2-related pathways and their involvement in both tumor and non-tumor diseases. Dysregulation of FOXR2 has been linked to numerous malignant tumors, spanning the brain, nervous system, thyroid, osteosarcoma, Hodgkin lymphoma, colorectal, liver, pancreatic, lung, breast, ovarian, prostate, female genital tract, endometrial, and uterine cancers. Despite extensive research on FOXR2 dysregulation, its practical applications remain underexplored. This review delves into the mechanisms underlying FOXR2 dysregulation during oncogenesis and its implications for cancer diagnosis, prognosis, and treatment.
format Artículo científico
id pubmed_39866234
institution PubMed
language en
publishDate 2025
publisher Oncology research
record_format pubmed
spellingShingle FOXR2 in cancer development: emerging player and therapeutic opportunities.
Yang, Piao
Sheykhhasan, Mohsen
Heidari, Reza
Chamanara, Mohsen
Dama, Paola
Ahmadieh-Yazdi, Amirhossein
Manoochehri, Hamed
Tanzadehpanah, Hamid
Mahaki, Hanie
Kalhor, Naser
Dirbaziyan, Ashkan
Al-Musawi, Sharafaldin
Humans
Neoplasms
Forkhead Transcription Factors
Animals
Prognosis
Carcinogenesis
Gene Expression Regulation, Neoplastic
FOXR2 in cancer development: emerging player and therapeutic opportunities. Yang, Piao Sheykhhasan, Mohsen Heidari, Reza Chamanara, Mohsen Dama, Paola Ahmadieh-Yazdi, Amirhossein Manoochehri, Hamed Tanzadehpanah, Hamid Mahaki, Hanie Kalhor, Naser Dirbaziyan, Ashkan Al-Musawi, Sharafaldin Humans Neoplasms Forkhead Transcription Factors Animals Prognosis Carcinogenesis Gene Expression Regulation, Neoplastic Cancer, a leading cause of global mortality, remains a significant challenge to increasing life expectancy worldwide. Forkhead Box R2 (FOXR2), identified as an oncogene within the FOX gene family, plays a crucial role in developing various endoderm-derived organs. Recent studies have elucidated FOXR2-related pathways and their involvement in both tumor and non-tumor diseases. Dysregulation of FOXR2 has been linked to numerous malignant tumors, spanning the brain, nervous system, thyroid, osteosarcoma, Hodgkin lymphoma, colorectal, liver, pancreatic, lung, breast, ovarian, prostate, female genital tract, endometrial, and uterine cancers. Despite extensive research on FOXR2 dysregulation, its practical applications remain underexplored. This review delves into the mechanisms underlying FOXR2 dysregulation during oncogenesis and its implications for cancer diagnosis, prognosis, and treatment.
title FOXR2 in cancer development: emerging player and therapeutic opportunities.
topic Humans
Neoplasms
Forkhead Transcription Factors
Animals
Prognosis
Carcinogenesis
Gene Expression Regulation, Neoplastic
url https://pubmed.ncbi.nlm.nih.gov/39866234/